Stock Events

Nuvectis Pharma 

$10.66
6
-$0.04-0.37% Today

Statistics

Day High
10.82
Day Low
10.05
52W High
18.65
52W Low
6.2
Volume
148,103
Avg. Volume
107,358
Mkt Cap
185.39M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

4MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-0.48
-0.32
-0.16
0
Expected EPS
-0.36
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVCT. It's not an investment recommendation.

Analyst Ratings

21$Average Price Target
The highest estimate is $21.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
Show more...
CEO
Employees
11
Country
US
ISIN
US67080T1088

Listings